Return On Equity of Panbela Therapeutics, Inc. from 30 Sep 2013 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Panbela Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2013 to 30 Sep 2024.
  • Panbela Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2024 was 305%, a 90% decline year-over-year.
  • Panbela Therapeutics, Inc. annual Return On Equity for 2023 was -73761%, a 7798% decline from 2022.
  • Panbela Therapeutics, Inc. annual Return On Equity for 2022 was 958%.
  • Panbela Therapeutics, Inc. annual Return On Equity for 2021 was -109%, a 16% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Panbela Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 305% -2634% -90% 01 Jul 2024 30 Sep 2024
Q2 2024 545% -348% -39% 01 Apr 2024 30 Jun 2024
Q1 2024 1953% +1172% +150% 01 Jan 2024 31 Mar 2024
Q4 2023 -73761% -74719% -7798% 01 Oct 2023 31 Dec 2023
Q3 2023 2939% +6607% 01 Jul 2023 30 Sep 2023
Q2 2023 893% +1389% 01 Apr 2023 30 Jun 2023
Q1 2023 781% +909% 01 Jan 2023 31 Mar 2023
Q4 2022 958% +1067% 01 Oct 2022 31 Dec 2022
Q3 2022 -3668% -3583% -4239% 01 Jul 2022 30 Sep 2022
Q2 2022 -495% -406% -456% 01 Apr 2022 30 Jun 2022
Q1 2022 -128% -51% -66% 01 Jan 2022 31 Mar 2022
Q4 2021 -109% -15% -16% 01 Oct 2021 31 Dec 2021
Q3 2021 -85% +62% +42% 01 Jul 2021 30 Sep 2021
Q2 2021 -89% +210% +70% 01 Apr 2021 30 Jun 2021
Q1 2021 -77% +509% +87% 01 Jan 2021 31 Mar 2021
Q4 2020 -94% +714% +88% 01 Oct 2020 31 Dec 2020
Q3 2020 -147% +1076% +88% 01 Jul 2020 30 Sep 2020
Q2 2020 -299% -2554% -113% 01 Apr 2020 30 Jun 2020
Q1 2020 -586% -3636% -119% 01 Jan 2020 31 Mar 2020
Q4 2019 -808% -1759% -185% 01 Oct 2019 31 Dec 2019
Q3 2019 -1223% -1678% -368% 01 Jul 2019 30 Sep 2019
Q2 2019 2254% +1873% +491% 01 Apr 2019 30 Jun 2019
Q1 2019 3049% +2760% +954% 01 Jan 2019 31 Mar 2019
Q4 2018 951% +303% +47% 01 Oct 2018 31 Dec 2018
Q3 2018 455% -112% -20% 01 Jul 2018 30 Sep 2018
Q2 2018 381% -89% -19% 01 Apr 2018 30 Jun 2018
Q1 2018 289% -88% -23% 01 Jan 2018 31 Mar 2018
Q4 2017 648% +505% +353% 01 Oct 2017 31 Dec 2017
Q3 2017 567% +450% +385% 01 Jul 2017 30 Sep 2017
Q2 2017 470% +347% +282% 01 Apr 2017 30 Jun 2017
Q1 2017 378% +211% +127% 01 Jan 2017 31 Mar 2017
Q4 2016 143% -227% -61% 01 Oct 2016 31 Dec 2016
Q3 2016 117% -530% -82% 01 Jul 2016 30 Sep 2016
Q2 2016 123% -1027% -89% 01 Apr 2016 30 Jun 2016
Q1 2016 167% -822% -83% 01 Jan 2016 31 Mar 2016
Q4 2015 370% -266% -42% 01 Oct 2015 31 Dec 2015
Q3 2015 647% +1724% 01 Jul 2015 30 Sep 2015
Q2 2015 1150% +1299% 01 Apr 2015 30 Jun 2015
Q1 2015 988% +1103% 01 Jan 2015 31 Mar 2015
Q4 2014 636% +712% 01 Oct 2014 31 Dec 2014
Q3 2014 -1077% -1123% -2408% 01 Jul 2014 30 Sep 2014
Q2 2014 -149% 01 Apr 2014 30 Jun 2014
Q1 2014 -115% 01 Jan 2014 31 Mar 2014
Q4 2013 -76% 01 Oct 2013 31 Dec 2013
Q3 2013 47% 01 Jul 2013 30 Sep 2013

Panbela Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 -73761% -74719% -7798% 01 Jan 2023 31 Dec 2023
2022 958% +1067% 01 Jan 2022 31 Dec 2022
2021 -109% -15% -16% 01 Jan 2021 31 Dec 2021
2020 -94% +714% +88% 01 Jan 2020 31 Dec 2020
2019 -808% -1759% -185% 01 Jan 2019 31 Dec 2019
2018 951% +303% +47% 01 Jan 2018 31 Dec 2018
2017 648% +505% +353% 01 Jan 2017 31 Dec 2017
2016 143% -227% -61% 01 Jan 2016 31 Dec 2016
2015 370% -266% -42% 01 Jan 2015 31 Dec 2015
2014 636% +712% 01 Jan 2014 31 Dec 2014
2013 -76% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.